We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 19 for:    Erlotinib AND Buffalo

Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01013831
First Posted: November 16, 2009
Last Update Posted: February 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
National Cancer Institute (NCI)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)